Document is current
Any future updates will be listed below
-
Authors
Liao, Wenfeng
Yu, Lianzi
Zhang, Lufang
Shao, Jie
Li, Guanhua
Hua, Jialei
Zhao, Shuya
Jia, Li
Han, Yawei
Zhang, Aimin
Yao, Xin
Li, Yueguo
Dong, Dong
-
Funding
Funding for this research was provided by:
Science & Technology Development Fund of Tianjin Education Commission for Higher Education (2020KJ138, 2020KJ129)
National Natural Science Foundation of China (81871719, 81502519)
Tianjin Key Medical Discipline (Specialty) Construction Project (TJYXZDXK-009A)
National Key Laboratory of Druggability Evaluation Systematic Translational Medicine (QZ23-8)
Joint Funds of the Natural Science Foundation of Tianjin (25JCLZJC00120)
- License Information
-
More Information
Article History
Received: 29 March 2025
Accepted: 9 September 2025
First Online: 8 October 2025
Declarations
:
: The study was approved by the Research Ethics Committee of Tianjin Medical University Cancer Institute and Hospital, and in accordance with the 1964 Helsinki Declaration ethical standards. All participants provided informed consent.
: Not applicable.
: The authors declare that they have no competing interests.
